Amussen Hunsaker Associates LLC Zynerba Pharmaceuticals, Inc. Transaction History

Amussen Hunsaker Associates LLC

  • $715 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 19, 2019
SELL
$2.89 - $7.91 $1,213 - $3,322
-420 Closed
0 $0
Q3 2018

Nov 16, 2018
BUY
$5.59 - $10.45 $1,118 - $2,090
200 Added 90.91%
420 $2,000
Q2 2018

Aug 16, 2018
BUY
$7.98 - $12.39 $1,755 - $2,725
220 New
220 $2,000

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Amussen Hunsaker Associates LLC Portfolio

Follow Amussen Hunsaker Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email